Piper Sandler Reiterates Overweight on Glaukos, Raises Price Target to $195

Benzinga · 1d ago
Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $165 to $195.